Literature DB >> 1462480

Study of kidney and liver viability in the rat after exclusive aortic perfusion using intracellular ATP measurement.

H Bittard1, L Chiche, M Moukarzel, D Douguet, G Benoit.   

Abstract

To find whether the liver can be procured after exclusive aortic perfusion, three organ perfusion models were used in three groups of donor rats. Group 1 underwent liver wash-out via the portal vein; in group 2, the kidneys alone were perfused via the aorta; and group 3 underwent simultaneous aortic perfusion of liver and kidneys. All perfusion flow rates in the three groups were adjusted to physiological values. Harvested organs were transplanted and recipient animals were killed 4 h after transplantation to study liver and kidney viability by using intracellular ATP measurement. Liver ATP was lower (P < 0.005) in the portal perfusion group (group 1: 1.396 +/- 0.412) than in the aortic perfusion group (group 3: 2.181 +/- 0.061). Kidney ATP was comparable in groups 2 and 3:1.066 +/- 0.09 vs 1.059 +/- 0.273 (mumol/g) tissue). Liver cooling was quicker with portal perfusion than with the aortic flush (20 degrees C in 20 s vs 15 degrees C in 60 s). Aortic perfusion at a physiologic flow rate has no detrimental effect on renal viability studied by intracellular ATP measurement. We conclude that liver cooling via the aortic route only is a good alternative to portal perfusion and seems to give good preservation. Application of this observation to emergency procurement in humans is still the subject of controversy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1462480     DOI: 10.1007/bf00294498

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  15 in total

1.  In situ preservation of cadaver kidneys for transplantation: laboratory observations and clinical application.

Authors:  R Garcia-Rinaldi; E A Lefrak; W W Defore; L Feldman; G P Noon; J A Jachimczyk; M E DeBakey
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

2.  [A double balloon catheter for the procurement of abdominal organs].

Authors:  G Benoit; H Bensadoun; I Borie; G Vavasseur; C Gillot
Journal:  Ann Urol (Paris)       Date:  1990

3.  The role of coenzyme Q10 for preservation of the rat kidney: a model experiment for kidney transplantation.

Authors:  Y Tatsukawa; Y Dohi; K Yamada; T Kawasaki
Journal:  Life Sci       Date:  1979-04-02       Impact factor: 5.037

4.  A new perfusion tube for multiple organ procurement.

Authors:  D Anaise; M J Yland; W C Waltzer; Z Frischer; F T Rapaport
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Preservation of organs for transplantation. Evidence of detrimental effect of rapid cooling.

Authors:  A Francavilla; T H Brown; R Fiore; S Cascardo; P Taylor; C G Groth
Journal:  Eur Surg Res       Date:  1973       Impact factor: 1.745

6.  Organ preservation.

Authors:  D E Pegg
Journal:  Surg Clin North Am       Date:  1986-06       Impact factor: 2.741

7.  The effect of cooling rate during perfusion on function and morphology of rabbit kidney grafts.

Authors:  I A Jacobsen; J Chemnitz; E Kemp; M R Buhl
Journal:  Scand J Urol Nephrol Suppl       Date:  1980

8.  Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate level.

Authors:  K Sumimoto; K Inagaki; K Yamada; T Kawasaki; K Dohi
Journal:  Transplantation       Date:  1988-10       Impact factor: 4.939

9.  Pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy. Clinical experience in 40 recipient patients.

Authors:  P N Bretan; N Baldwin; A C Novick; A Majors; K Easley; T Ng; N Stowe; P Rehm; S B Streem; D R Steinmuller
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

10.  Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation.

Authors:  W Kamiike; M Burdelski; G Steinhoff; B Ringe; W Lauchart; R Pichlmayr
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.